2 minutes with: Vaish Manoharan-Jayarajah on rapid recombinant protein optimization
![](https://www.biotechniques.com/wp-content/uploads/2025/02/Nuclera-header-image-800x344.png)
Nuclera (Cambridge, UK) is a biotech company that specializes in rapid protein expression and purification optimization at the benchtop. With the aim of streamlining the drug discovery process, Nuclera has developed the eProtein DiscoveryTM benchtop system, which can be used to express, purify and detect proteins for use in drug discovery processes such as assay development, high-throughput screening and structure characterization. We caught up with Nuclera’s Key Account Manager, Vaish Manoharan-Jayarajah, at ELRIG Drug Discovery 2024 (2–3 October; London, UK) to learn a bit more about rapid protein expression and purification optimization and how it’s transforming the drug discovery field....
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!